Evidence map›Paper›PMID 19218347›Full record

ArticleThe American journal of pathology2009

Gallbladder epithelial cells that engraft in mouse liver can differentiate into hepatocyte-like cells.

Sum P Lee, Christopher E Savard, Rahul Kuver

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Liver bioengineering: current status and future perspectives.World journal of gastroenterology · 2012
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sum P LeeDivision of Gastroenterology, Department of Medicine, University of Washington, Puget Sound Veterans Affairs Health Care System, Seattle, WA 98195, USA.
Christopher E Savard
Rahul Kuver
VA Puget Sound Health Care System · US

Funding

Regulation of cell lineage specificity in the liverR01DK061157 · NIDDK · UNIVERSITY OF WASHINGTON · PI LEE, SUM P · 2003 to 2005
$771k
NIDDK NIH HHS DK-061157NIDDK NIH HHS R01 DK061157
6 · The paper itself

Abstract

We tested the hypothesis that well-differentiated gallbladder epithelial cells (GBECs) are capable of engrafting and surviving in murine liver and acquire phenotypic characteristics of hepatocytes. GBECs isolated from transgenic mice that constitutively express green fluorescent protein (GFP) were either cultured before transplantation or transplanted immediately following isolation. Recipient mice with severe-combined immunodeficiency underwent retrorsine treatment and either partial hepatectomy before transplantation or carbon tetrachloride treatment following transplantation. From 1 to 4 months following transplantation, the livers of recipient mice contained discrete colonies of GFP(+) cells. Most GFP(+) cells surrounded vesicles, were epithelial cell-like in morphology, and expressed the biliary epithelial markers cytokeratin 19 and carbonic anhydrase IV. Subpopulations of GFP(+) cells resembled hepatocytes morphologically and expressed the hepatocyte-specific markers connexin-32 and hepatic nuclear factor-4alpha, but not cytokeratin 19 or carbonic anhydrase IV. At 4 months, cells in GFP(+) colonies were not actively proliferating as determined by proliferating cell nuclear antigen expression. Thus, GBECs are capable of engrafting and surviving in damaged mouse livers, and some can differentiate into cells with hepatocyte-like features. These findings suggest that environmental cues in the recipient liver are sufficient to allow a subpopulation of donor GBECs to differentiate into hepatocyte-like cells in the absence of exogenous transcriptional reprogramming. GBECs might be used as donor cells in a cell transplantation approach for the treatment of liver disease.

Indexed as

AnimalsCell DifferentiationCell SurvivalConnexinsEpithelial CellsGallbladderGap Junction beta-1 ProteinGenes, ReporterGreen Fluorescent ProteinsHepatocyte Nuclear Factor 4HepatocytesLiverMiceMice, TransgenicConnexinsGap Junction beta-1 ProteinGreen Fluorescent ProteinsHepatocyte Nuclear Factor 4

Identifiers

PMID19218347
PMCPMC2665745
OpenAlexW2097138954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.